Nanocytology Test to Evaluate Skin Cancer in High Risk Patients

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Actinic KeratosisSquamous Cell Carcinoma
Interventions
PROCEDURE

Superficial shave biopsy

Sample will be obtained from random dorsal forearm skin sites without evidence of keratotic lesions. The site will be selected by the investigator. Skin will first be wiped with an alcohol pad and 1% lidocaine will be superficially infiltrated per standard skin surgical procedures. 30% trichloroacetic acid (TCA, standard chemical peel) will then be applied for five minutes. TCA will be neutralized using bicarbonate. Using a cytology brush (a small brush which is used to collect cells during the course of a biopsy) cells will be collected by gentle scraping surface of the skin. Then, a superficial shave biopsy specimen, obtained by using a dermablade (a flexible, one piece blade specifically designed for shave biopsy and excision of skin lesions) will be obtained.

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01905891 - Nanocytology Test to Evaluate Skin Cancer in High Risk Patients | Biotech Hunter | Biotech Hunter